Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Calvert International Equity C CWVCX
- NAV / 1-Day Return 19.39 / +1.15 %
- Total Assets 1.0 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.890%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.28%
- Turnover 35%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis CWVCX
Will CWVCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Nestle SA | 5.54 | 58.5 Mil | Consumer Defensive |
AstraZeneca PLC | 4.30 | 45.3 Mil | Healthcare |
ASML Holding NV | 4.20 | 44.3 Mil | Technology |
Novo Nordisk A/S Class B | 4.06 | 42.8 Mil | Healthcare |
Iberdrola SA | 3.97 | 42.0 Mil | Utilities |
Compass Group PLC | 3.75 | 39.6 Mil | Consumer Cyclical |
Siemens AG | 3.35 | 35.3 Mil | Industrials |
Sanofi SA | 3.31 | 35.0 Mil | Healthcare |
Reckitt Benckiser Group PLC | 3.13 | 33.0 Mil | Consumer Defensive |
HSBC Holdings PLC | 3.06 | 32.3 Mil | Financial Services |